(Reuters) - The U.S. Food and Drug Administration has approved monthly maintenance dosing for Japan's Eisai ( ESALF ) and partner Biogen's Alzheimer's drug Leqembi, the companies said on Monday. The drug received standard U.S. approval in 2023 after showing it slowed cognitive decline in patients with the brain-wasting disease but growth has been slow, in part because its administration...

MEXICO CITY (Reuters) - The Mexican peso depreciated in international trade after U.S President Donald Trump announced he would impose tariffs on Colombia, reviving concerns about his trade policy. The currency, one of the most liquid currencies globally, was trading at 20.4630 units per dollar, down 1% compared to the London Stock Exchange Group reference price on Friday. Tariffs on...

Jan 27 (Reuters) - The U.S. Food and Drug Administration has approved monthly maintenance dosing for Japan's Eisai ( ESALF ) and partner Biogen's Alzheimer's drug Leqembi, the companies said on Monday. The drug received standard U.S. approval in 2023 after showing it slowed cognitive decline in patients with the brain-wasting disease but growth has been slow, in part because...

Jan 26 (Reuters) - Diversified Energy ( DEC ) is in advanced talks to buy private equity-owned Maverick Natural Resources, the Wall Street Journal reported on Sunday. A deal would value Maverick at about $1.3 billion including debt, the report said, adding that it could be announced as soon as early Monday. ...